Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus

Vaccine

Volumn 31, Issue 40, 2013, Pages 4330-4337

  Vu, Hiep L X ^a   Kwon, Byungjoon ^a   de Lima, Marcelo ^b   Pattnaik, Asit K ^a   Osorio, Fernando A ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

DIVA vaccines; M protein; PRRSV; Serological marker epitope

Indexed keywords

EPITOPE; LIVE ATTENUATED DIVA VACCINE; LIVE VACCINE; M PROTEIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; IMMUNE RESPONSE; IMMUNOGENICITY; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS REPLICATION;

DIVA VACCINES; M PROTEIN; PRRSV; SEROLOGICAL MARKER EPITOPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; EPITOPES; GLYCOPROTEINS; MICE; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; SWINE DISEASES; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 84882822947     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.020     Document Type: Article

References (47)

1. Hill H. Overview and history of mystery swine disease (swine infertility and respiratory syndrome) 1990, 29-30.
2. Rossow K.D. Porcine reproductive and respiratory syndrome. Veterinary Pathology 1998, 35(January (1)):1-20.
3. Tian K., Yu X., Zhao T., Feng Y., Cao Z., Wang C., et al. Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark. PLoS One 2007, 2(6):e526.
4. Wensvoort G., Terpstra C., Pol J.M., ter Laak E.A., Bloemraad M., de Kluyver E.P., et al. Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Veterinary Quarterly 1991, 13(July (3)):121-130.
5. Cavanagh D. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Archives of Virology 1997, 142(3):629-633.
6. Collins J.E., Benfield D.A., Christianson W.T., Harris L., Hennings J.C., Shaw D.P., et al. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. Journal of Veterinary Diagnostic Investigation 1992, 4(April (2)):117-126.
7. Meulenberg J.J., Petersen den Besten A., de Kluyver E., van Nieuwstadt A., Wensvoort G., Moormann R.J. Molecular characterization of Lelystad virus. Veterinary Microbiology 1997, 55(April (1/4)):197-202.
8. Conzelmann K.K., Visser N., Van Woensel P., Thiel H.J. Molecular characterization of porcine reproductive and respiratory syndrome virus, a member of the arterivirus group. Virology 1993, 193(March (1)):329-339.
9. Snijder E., Spaan W.J. Ateriviruses. Fields virology 2007, 1337-1355. Lippincott Williams & Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
10. Osorio F.A., Zuckermann F., Wills R., Meier W., Christian S., Galeota J., et al. PRRSV: comparison of commercial vaccines in their ability to induce protection against current PRRSV strains of high virulence. Allen D Leman Swine Conference 1998, 25:176-182.
11. Zuckermann F.A., Garcia E.A., Luque I.D., Christopher-Hennings J., Doster A., Brito M., et al. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Veterinary Microbiology 2007, 123(July 20 (1/3)):69-85.
12. Alexopoulos C., Kritas S.K., Kyriakis C.S., Tzika E., Kyriakis S.C. Sow performance in an endemically porcine reproductive and respiratory syndrome (PRRS)-infected farm after sow vaccination with an attenuated PRRS vaccine. Veterinary Microbiology 2005, 111(December 20 (3/4)):151-157.
13. Pejsak Z., Markowska-Daniel I. Randomised, placebo-controlled trial of a live vaccine against porcine reproductive and respiratory syndrome virus in sows on infected farms. Veterinary Record 2006, 158(April 8 (14)):475-478.
14. Prieto C., Alvarez E., Martinez-Lobo F.J., Simarro I., Castro J.M. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred. Veterinary Journal 2008, 175(March (3)):356-363.
15. Diaz I., Darwich L., Pappaterra G., Pujols J., Mateu E. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology 2006, 351(August 1 (2)):249-259.
16. Christopher-Hennings J., Nelson E.A., Nelson J.K., Benfield D.A. Effects of a modified-live virus vaccine against porcine reproductive and respiratory syndrome in boars. American Journal of Veterinary Research 1997, 58(January (1)):40-45.
17. van Oirschot J.T. Diva vaccines that reduce virus transmission. Journal of Biotechnology 1999, 73(August 20 (2/3)):195-205.
18. Capua I., Schmitz A., Jestin V., Koch G., Marangon S. Vaccination as a tool to combat introductions of notifiable avian influenza viruses in Europe, 2000 to 2006. Revue Scientifique et Technique 2009, 28(April (1)):245-259.
19. van Oirschot J.T., Kaashoek M.J., Rijsewijk F.A., Stegeman J.A. The use of marker vaccines in eradication of herpesviruses. Journal of Biotechnology 1996, 44(January 26 (1/3)):75-81.
20. Welch S.K., Jolie R., Pearce D.S., Koertje W.D., Fuog E., Shields S.L., et al. Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates. Veterinary Immunology and Immunopathology 2004, 102(December 8 (3)):277-290.
21. Lee C., Yoo D. The small envelope protein of porcine reproductive and respiratory syndrome virus possesses ion channel protein-like properties. Virology 2006, 355(November 10 (1)):30-43.
22. Sun L., Li Y., Liu R., Wang X., Gao F., Lin T., et al. Porcine reproductive and respiratory syndrome virus ORF5a protein is essential for virus viability. Virus Research 2013, 171(January (1)):178-185.
23. Wissink E.H., Kroese M.V., van Wijk H.A., Rijsewijk F.A., Meulenberg J.J., Rottier P.J. Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus. Journal of Virology 2005, 79(October (19)):12495-12506.
24. Uddowla S., Hollister J., Pacheco J.M., Rodriguez L.L., Rieder E. A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. Journal of Virology 2012, 86(November (21)):11675-11685.
25. Castillo-Olivares J., Wieringa R., Bakonyi T., de Vries A.A., Davis-Poynter N.J., Rottier P.J. Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain. Journal of Virology 2003, 77(August (15)):8470-8480.
26. Holinka L.G., Fernandez-Sainz I., O'Donnell V., Prarat M.V., Gladue D.P., Lu Z., et al. Development of a live attenuated antigenic marker classical swine fever vaccine. Virology 2009, 384(February 5 (1)):106-113.
27. de Lima M., Pattnaik A.K., Flores E.F., Osorio F.A. Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus. Virology 2006, 353:410-421.
28. Das P.B., Vu H.L., Dinh P.X., Cooney J.L., Kwon B., Osorio F.A., et al. Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response. Virology 2011, 410(February 20 (2)):385-394.
29. Vu H.L., Kwon B., Yoon K.J., Laegreid W.W., Pattnaik A.K., Osorio F.A. Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3. Journal of Virology 2012, 85(June (11)):5555-5564.
30. Kwon B., Ansari I.H., Osorio F.A., Pattnaik A.K. Infectious clone-derived viruses from virulent and vaccine strains of porcine reproductive and respiratory syndrome virus mimic biological properties of their parental viruses in a pregnant sow model. Vaccine 2006, 24(November 30 (49/50)):7071-7080.
31. Beura L.K., Sarkar S.N., Kwon B., Subramaniam S., Jones C., Pattnaik A.K., et al. Porcine reproductive and respiratory syndrome virus nonstructural protein 1beta modulates host innate immune response by antagonizing IRF3 activation. Journal of Virology 2010, 84(February (3)):1574-1584.
32. Sarkar G., Sommer S.S. The "megaprimer" method of site-directed mutagenesis. Biotechniques 1990, 8(April (4)):404-407.
33. Truong H.M., Lu Z., Kutish G.F., Galeota J., Osorio F.A., Pattnaik A.K. A highly pathogenic porcine reproductive and respiratory syndrome virus generated from an infectious cDNA clone retains the in vivo virulence and transmissibility properties of the parental virus. Virology 2004, 325(August 1 (2)):308-319.
34. Ansari I.H., Kwon B., Osorio F.A., Pattnaik A.K. Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. Journal of Virology 2006, 80(April (8)):3994-4004.
35. Subramaniam S., Beura L.K., Kwon B., Pattnaik A.K., Osorio F.A. Amino acid residues in the non-structural protein 1 of porcine reproductive and respiratory syndrome virus involved in down-regulation of TNF-alpha expression in vitro and attenuation in vivo. Virology 2012, 432(October 25 (2)):241-249.
36. Hesse R., Couture L., Lau M., Wunder K., Wasmoen T. Efficacy of Prime Pac PRRS in controlling PRRS reproductive disease: heterologous challenge 1996, 107-110.
37. Brown E., Lawson S., Welbon C., Gnanandarajah J., Li J., Murtaugh M.P., et al. Antibody response of nonstructural proteins: implications for diagnostic detection and differentiation of Type I and Type II porcine reproductive and respiratory syndrome viruses. Clinical and Vaccine Immunology 2009, 4(March (16)):628-635.
38. Yoon K.J., Zimmerman J.J., Swenson S.L., McGinley M.J., Eernisse K.A., Brevik A., et al. Characterization of the humoral immune response to porcine reproductive and respiratory syndrome (PRRS) virus infection. Journal of Veterinary Diagnostic Investigation 1995, 7(July (3)):305-312.
39. Kapur V., Elam M.R., Pawlovich T.M., Murtaugh M.P. Genetic variation in porcine reproductive and respiratory syndrome virus isolates in the Midwestern United States. Journal of General Virology 1996, 77(June (Pt 6)):1271-1276.
40. Johnson C.R., Yu W., Murtaugh M.P. Cross-reactive antibody responses to nsp1 and nsp2 of Porcine reproductive and respiratory syndrome virus. Journal of General Virology 2007, 88(April (Pt 4)):1184-1195.
41. Kim D.Y., Kaiser T.J., Horlen K., Keith M.L., Taylor L.P., Jolie R., et al. Insertion and deletion in a non-essential region of the nonstructural protein 2 (nsp2) of porcine reproductive and respiratory syndrome (PRRS) virus: effects on virulence and immunogenicity. Virus Genes 2009, 38(February (1)):118-128.
42. de Lima M., Kwon B., Ansari I.H., Pattnaik A.K., Flores E.F., Osorio F.A. Development of a porcine reproductive and respiratory syndrome virus differentiable (DIVA) strain through deletion of specific immunodominant epitopes. Vaccine 2008, 26(July 4 (29/30)):3594-3600.
43. Fang Y., Christopher-Hennings J., Brown E., Liu H., Chen Z., Lawson S.R., et al. Development of genetic markers in the non-structural protein 2 region of a US type 1 porcine reproductive and respiratory syndrome virus: implications for future recombinant marker vaccine development. Journal of General Virology 2008, 89(December (Pt 12)):3086-3096.
44. Han J., Wang Y., Faaberg K.S. Complete genome analysis of RFLP 184 isolates of porcine reproductive and respiratory syndrome virus. Virus Research 2006, 122(December (1/2)):175-182.
45. Yoshii M., Okinaga T., Miyazaki A., Kato K., Ikeda H., Tsunemitsu H. Genetic polymorphism of the nsp2 gene in North American type - porcine reproductive and respiratory syndrome virus. Archives of Virology 2008, 153(7):1323-1334.
46. Spilman M.S., Welbon C., Nelson E., Dokland T. Cryo-electron tomography of porcine reproductive and respiratory syndrome virus: organization of the nucleocapsid. Journal of General Virology 2009, 90(March (Pt 3)):527-535.
47. Beura L.K., Subramaniam S., Vu H.L., Kwon B., Pattnaik A.K., Osorio F.A. Identification of amino acid residues important for anti-IFN activity of porcine reproductive and respiratory syndrome virus non-structural protein 1. Virology 2012, 433(November 25 (2)):431-439.